Effects of 2-chloroadenosine on cortical epileptic afterdischarges in immature rats

Pharmacological Reports

Volumn 62, Issue 1, 2010, Pages 62-67

  Pometlová, Marie ^a   Kubová, Hana ^b   Mareš, Pavel ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

2 chloroadenosine; Afterdischarges; Cerebral cortex; Electrical stimulation; Ontogeny; Rat

Indexed keywords

2 CHLOROADENOSINE;

ADRENAL CORTEX; AFTERDISCHARGE; AGE DETERMINATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CLONIC SEIZURE; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG DOSE COMPARISON; DRUG EFFICACY; ELECTRODE; ELECTROENCEPHALOGRAPHY; ELECTROSTIMULATION; EPILEPSY; EXPERIMENTAL RAT; JUVENILE ANIMAL; NONHUMAN; OUTCOME ASSESSMENT; RAT; TREATMENT DURATION;

EID: 77950793631     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(10)70243-7     Document Type: Article

References (33)

1. Abdul-Ghani AS, Attwell PJ, Bradford HF: The protec-tive effect of 2-chloroadenosine against the development of amygdala kindling and on amygdala-kindled seizures. Eur J Pharmacol, 1997, 325, 7-14.
2. Adén U, Leverin A-L, Hagberg H, Fredholm BB: Adenosine A receptor agonism in the immature rat brain and heart. Eur J Pharmacol, 2001, 426, 185-192.
3. Altman J, Sudarshan K: Postnatal development of loco-motion in the laboratory rat. Anim Behav, 1975, 23, 896-920.
4. Bernášková K, Mareš P: Proconvulsant effect of amino-phylline on cortical epileptic afterdischarges varies dur-ing ontogeny. Epilepsy Res, 2000, 39, 183-190.
5. Boison D: Adenosine as a modulator of brain activity. Drug News Perspect 2007, 20, 607-611.
6. Borowicz KK, Łuszczki J, Czuczwar SJ: 2-Chloroadenosine, a preferential agonist of adenosine A1 receptors, en-hances the anticonvulsant activity of carbamazepine and clonazepam in mice. Eur Neuropsychopharmacol, 2002, 12,173-179.
7. Cavalheiro EA, Calderazzo Filho LS, Bortolotto ZA, Mello L, Turski L: Anticonvulsant role of adenosine. Pol J Pharmacol, 1987, 39, 537-543.
8. Chrościńska-Krawczyk M, Ratnaraj N, Patsalos PN, Czuczwar SJ: Effect of caffeine on the anticonvul-sant effects of oxcarbazepine, lamotrigine and tiagabine in a mouse model of generalized tonic-clonic seizures. Pharmacol Rep, 2009, 61, 819-826.
9. Chu N-S: Caffeine- and aminophylline-induced seizures. Epilepsia, 1981, 22, 85-94.
10. Descombes S, Avoli M, Psarropoulou C: A comparison of the adenosine-mediated synaptic inhibition in the CA3 area of immature and adult rat hippocampus. Develop Brain Res, 1998, 110, 51-59.
11. Dragunow M: Purinergic mechanisms in epilepsy. Progr Neurobiol, 1988, 31, 85-108.
12. Dragunow M, Goddard GV, Laverty R: Is adenosine an endogenous anticonvulsant? Epilepsia, 1985, 26, 480-487.
13. Dunwiddie TV: Adenosine and suppression of seizures. In: Jasper's Basic Mechanisms of the Epilepsies. Eds. Delgado-Escueta A, Wilson WA, Olsen RW, Porter RJ, Lippincott Williams and Wilkins, Philadelphia, 1999, 1001-1010.
14. Dunwiddie TV, Masino SA: The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci, 2001, 24, 31-55.
15. During MJ, Spencer DD: Adenosine: a potential media-tor of seizure arrest and postictal refractoriness. Ann Neurol, 1992, 32, 618-624.
16. Francis A, Fochtmann L: Caffeine augmentation of electroconvulsive seizures. Psychopharmacology, 1994, 115, 320-324.
17. Geiger JD, LaBella FS, Nagy JI: Ontogeny of adenosine receptors in the central nervous system of the rat. Develop Brain Res, 1984, 13, 97-104.
18. George B, Kulkarni SK: Modulation of lithium-pilocarpine-induced status epilepticus by adenosinergic agents. Meth Find Exp Clin Pharmacol, 1997, 19, 329-333.
19. Handforth A, Treiman DM: Effect of an adenosine antagonist and an adenosine agonist on status entry and severity in a model of limbic status epilepticus. Epilepsy Res, 1994, 18, 29-42.
20. Hauser WA, Annegers JF, Kurland LT: Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia, 1993, 34, 543-568.
21. Marangos PJ, Patel J, Stivers J: Ontogeny of adenosine binding sites in rat forebrain and cerebellum. J Neurochem, 1982, 39, 267-270.
22. Mareš P, Haugvicová R, Kubová H: Unequal development of thresholds for various phenomena induced by cortical stimulation in rats. Epilepsy Res 2002, 49, 35-43.
23. Mareš P, Kubová H: What is the role of neurotransmitter systems in cortical seizures? Physiol Res, 2008, 57, Suppl 3, S111-S120.
24. Mareš P, Kubová H, Czuczwar SJ: Aminophylline exhibits convulsant action in rats during ontogenesis. Brain Dev, 1994, 16, 296-300.
25. Mareš P, Marešová D, Trojan S, Fischer J: Ontogenetic development of rhythmic thalamo-cortical phenomena in the rat. Brain Res Bull, 1982, 8, 765-769.
26. Mareš P, Šlamberová R: Efficacy of bretazenil against cortical epileptic aferdischarges increases during early ontogeny in rats. Pharmacol Rep, 2006, 58, 519-525.
27. Mareš P, Tabashidze N: Contradictory effects of GABA-B receptor agonists on cortical epileptic afterdis-charges in immature rats. Brain Res Bull, 2008, 75, 173-178.
28. Morgan PF, Deckert J, Jacobson KA, Marangos PJ, Daly JW: Potent convulsant actions of the adenosine receptor antagonist, xanthine amine congener (XAC). Life Sci, 1989,45,719-728.
29. Nabbout R, Dulac O: Epileptic syndromes in infancy and childhood. Curr Opin Neurol, 2008, 21, 161-166.
30. Pagonopoulou O, Efthimiadou A, Asimakopoulos B, Nikolettos NK: Modulatory role of adenosine and its receptors in epilepsy: Possible therapeutic approaches. Neurosci Res, 2006, 56, 14-20.
31. Polášek R, Kubová H, Šlamberová R, Mareš P, Vorlíèek J: Suppression of cortical epileptic afterdischarges in developing rats by anticonvulsants increasing GABAergic\ inhibition. Epilepsy Res, 1996, 25, 177-184.
32. Racine RJ: Modification of seizure activity by electrical stimulation: II. Motor seizures. Electroenceph Clin Neurophysiol, 1972, 32, 281-294.
33. Trommer BL, Pasternak JF, Suyeoka GM: Proconvulsant effects of aminophylline during amygdala kinding in developing rats. Dev Brain Res, 1989, 46, 169-172.